Ayón Chang, C., Castán, D., Mora Carmona, A., Naranjo, D., Obando, F., & Mora Román, J. J. (2022). Monoclonal antibodies: A therapeutic option for the treatment of ophthalmic diseases of the eye posterior segment.
Chicago Style CitationAyón Chang, Catalina, Daniel Castán, Adrián Mora Carmona, Dunia Naranjo, Francini Obando, and Juan José Mora Román. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
MLA CitationAyón Chang, Catalina, et al. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
Warning: These citations may not always be 100% accurate.